A new weight loss drug developed by Amgen may provide better results with fewer injections than current treatments such as ...

Losing weight is difficult, but keeping it off can be harder. Have you ever wondered why? Memory in fat cells may contribute ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...

You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. Happy ...

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

"Inside the NBA" featured some more cracks between colleagues on Tuesday night, as Shaquille O'Neal called for the "Ozempic ...

Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of nearly 600 ...

The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...

Suffolk County employees and beneficiaries hoping to shed pounds using the latest weight-loss medications will face stricter ...